D-0136-2020 Class II Terminated

Recalled by Pfizer Inc. — New York, NY

FDA drug recall D-0136-2020 was initiated by Pfizer Inc. on Oct 2, 2019 and is designated Class II. Reason for recall: Lack of Assurance of Sterility: Bag has the potential to leak. The recall status is terminated (terminated Dec 1, 2020). Affected quantity: 17832 bags.

Recall details

Product Type
Drugs
Report Date
Oct 16, 2019
Initiation Date
Oct 2, 2019
Termination Date
Dec 1, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
17832 bags

Product description

10% LMD in 5% Dextrose Injection Dextran 40 in Dextrose Injection, USP, 500 mL bags, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-7418-13

Reason for recall

Lack of Assurance of Sterility: Bag has the potential to leak.

Distribution pattern

Nationwide in the United States and Puerto Rico

Code information

Lot #: 87-095-JT Exp. 1MAR2020

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0136-2020
openFDA file date
Nov 19, 2026
Loaded by RegDataLab
Nov 20, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Need the full FDA record for Pfizer Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: openFDA record for D-0136-2020. Report a data issue: hello@regdatalab.com.